COVID-19 in a human T-cell lymphotropic virus type-1 carrier.
COVID‐19
SARS‐CoV‐2
coinfection
human T‐cell lymphotropic virus type‐1
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
17
08
2021
revised:
28
01
2022
accepted:
01
02
2022
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
1
3
2022
Statut:
epublish
Résumé
This is the first report of COVID-19 in a human T-cell lymphotropic virus type-1 (HTLV-1) carrier. HTLV-1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID-19-HTLV-1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.
Identifiants
pubmed: 35223018
doi: 10.1002/ccr3.5463
pii: CCR35463
pmc: PMC8847415
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e05463Informations de copyright
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
All authors declare that they have no competing interests.
Références
Blood. 2001 May 15;97(10):3177-83
pubmed: 11342446
J Infect. 2020 Apr;80(4):388-393
pubmed: 32112884
Cytokine Growth Factor Rev. 2011 Aug;22(4):197-210
pubmed: 21924945
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
J Med Virol. 2005 Nov;77(3):331-6
pubmed: 16173022
Lancet Infect Dis. 2007 Apr;7(4):266-81
pubmed: 17376384
Clin Infect Dis. 2020 Jul 28;71(15):740-747
pubmed: 32211844
Pathogens. 2020 Jun 03;9(6):
pubmed: 32503140
J Fungi (Basel). 2020 Oct 08;6(4):
pubmed: 33050019
Am J Respir Crit Care Med. 2021 Feb 1;203(3):307-317
pubmed: 33480831
Crit Care. 2020 Aug 28;24(1):530
pubmed: 32859241
Transfusion. 2016 Feb;56(2):457-65
pubmed: 26509432
J Clin Exp Hematop. 2020 Dec 15;60(4):174-178
pubmed: 32879154